A new comprehensive study highlights the transformative expansion underway in the global market for ultra-long-acting hormonal drugs (ULADs) Market a sector rapidly redefining the treatment landscape for chronic hormonal and reproductive health conditions. Valued at $5.40 billion in 2024, the market is projected to reach $13.96 billion by 2032, demonstrating an exceptional Compound An... https://www.databridgemarketresearch.com/